The FDA has approved a label update for Eli Lilly’s Kisunla, an Alzheimer’s treatment, by modifying the recommended dosing schedule for adults with early symptomatic Alzheimer’s disease. The update ...

In the past, if you had a question or curiosity about global norms, you'd probably talk it over with friends, family, or ...